We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

FAPON

Fapon is a global IVD raw materials & one-stop solutions company offering 700+ reagent raw materials for the applicat... read more Featured Products: More products

Download Mobile App





Fapon Presents AI-Driven Diagnostic Innovation and Advanced Alzheimer's Disease Blood Testing Solutions

By LabMedica International staff writers
Posted on 18 Nov 2025

Fapon, a global leader in life sciences, is participating at MEDICA 2025 from November 17 to 20 in Düsseldorf, Germany, where it is underscoring its strengths in diagnostic innovation. More...

At booth A81 in Hall 3, the company is presenting how AI-driven technologies are advancing diagnostic R&D and unveiling a range of IVD solutions and new products, with particular emphasis on its state-of-the-art blood testing solutions for Alzheimer’s disease (AD).

Fapon’s “AI-driven + closed-loop dry and wet experimentation” R&D model greatly enhances the efficiency of biomarker discovery and the development of diagnostic solutions. A standout achievement of this approach is the company’s advanced AD blood testing solution. Designed to support IVD manufacturers, it offers a complete suite of raw materials and bulk reagents for core Alzheimer’s biomarkers, including p-tau 217, p-tau 181, amyloid beta 40, amyloid beta 42, GFAP, NfL, and APOE4. These innovative materials deliver high sensitivity and specificity, with strong concordance to predicate kits and established clinical tests, enabling the development of more precise and reliable AD assays.

Fapon is also presenting its full suite of one-stop IVD solutions, encompassing raw materials, reagent development services, and open-platform instruments. A highlight is the chemiluminescence one-stop solution, which integrates high-performance core materials, a panel of more than 70 self-developed assays, and the versatile Shine i-Series CLIA analyzers encompassing low to ultra-high throughput to address testing demands across diverse clinical settings. Additionally, the Shine mT8000 Fully Automatic Clinical Chemistry and Immunoassay System provides end-to-end workflow automation within a compact, space-efficient footprint of just 5 m².

Fapon is also showcasing its portfolio of high-performance IVD raw materials, including recombinant quality-control and calibrator components for key disease markers such as RF, HbA1c, HIV/HIV-P24, HCV, TP, HBV, and ToRCH. The company is further highlighting its animal-origin-free IgG blockers and LAMP solutions designed for rapid molecular testing.

Related Links:
Fapon Biotech


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
HPV Test
Allplex HPV28 Detection
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image Credit: Adobe Stock

Machine Learning Cytology Tool Improves Cancer Cell Identification

Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.